LNTH - Lantheus Holdings, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $1.18
|
Rev Est: $367.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$77.00
DETAILS
HIGH:
$82.00
LOW:
$72.00
MEDIAN:
$77.00
CONSENSUS:
$77.00
UPSIDE:
4.61%
Market Cap:
5.01B
Volume:
876,597
Avg Volume:
929,213
52 Week Range:
47.25-111.29
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
-0.09
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
808
IPO Date:
2015-06-25
EPS (TTM):
4.52
P/E Ratio:
19.81
Revenue (TTM):
1.53B
Total Assets:
1.98B
Total Debt:
619.44M
Cash & Equiv:
912.81M
Rev Growth (5Y):
34.6%
EPS Growth (5Y):
41.0%
FCF Growth (5Y):
53.2%
ROCE:
25.9%
Debt/Equity:
0.57
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $1.27 | $1.27 | 0.0% | $384.0M | $368.0M | +4.4% |
| 2025-08-06 | $1.57 | $1.64 | -4.3% | $378.0M | $363.3M | +4.0% |
| 2025-05-07 | $1.53 | $1.68 | -8.9% | $372.8M | $395.2M | -5.7% |
| 2025-02-26 | $1.59 | $1.58 | +0.6% | $391.1M | $379.5M | +3.1% |
| 2024-11-06 | $1.70 | $1.56 | +9.0% | $378.7M | $375.9M | +0.8% |
| 2024-07-31 | $1.80 | $1.83 | -1.6% | $394.1M | $382.1M | +3.1% |
| 2024-05-02 | $1.69 | $1.54 | +9.7% | $370.0M | $382.1M | -3.2% |
| 2024-02-22 | $1.75 | $1.45 | +20.7% | $354.0M | $342.3M | +3.4% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.53B | 1.30B | 935.06M | 425.21M | 339.41M | 347.34M | 343.37M | 331.38M | 301.85M | 293.46M | 301.60M | 283.67M |
| Net Income | 312.44M | 326.66M | 28.07M | (71.28M) | (13.47M) | 31.67M | 40.52M | 123.39M | 26.76M | (14.75M) | (3.56M) | (61.55M) |
| EPS | 4.52 | 4.79 | 0.41 | -1.06 | -0.25 | 0.81 | 1.06 | 3.31 | 0.84 | -0.60 | -0.20 | -3.40 |
| Total Assets | 1.98B | 1.65B | 1.32B | 863.78M | 869.82M | 405.92M | 439.83M | 383.86M | 255.90M | 242.38M | 249.57M | 261.31M |
| Total Debt | 619.44M | 616.95M | 583.51M | 191.31M | 235.90M | 194.40M | 266.46M | 268.14M | 278.11M | 353.51M | 407.28M | 407.04M |
| Cash & Equivalents | 912.81M | 713.66M | 415.65M | 98.51M | 79.61M | 92.92M | 113.40M | 76.29M | 51.18M | 28.60M | 19.74M | 18.58M |
| Operating Cash Flow | 544.75M | 305.26M | 281.78M | 53.92M | 16.40M | 80.38M | 61.19M | 54.78M | 49.64M | 21.76M | 11.59M | (15.57M) |
| Free Cash Flow | 493.12M | 258.70M | 263.43M | 41.78M | 3.92M | 58.32M | 41.06M | 37.23M | 42.24M | 8.61M | 3.45M | (20.58M) |
| FCF per Share | 7.13 | 3.79 | 3.85 | 0.62 | 0.07 | 1.50 | 1.07 | 1.00 | 1.32 | 0.35 | 0.19 | -1.14 |
| Book Value | 1.09B | 815.89M | 447.15M | 464.44M | 514.21M | 114.60M | 71.00M | 23.29M | (106.52M) | (185.29M) | (239.27M) | (235.52M) |
| Cash & ST Investments | 912.81M | 713.66M | 415.65M | 98.51M | 79.61M | 92.92M | 113.40M | 76.29M | 51.18M | 28.60M | 19.74M | 18.58M |
| ROC Equity | 0.29 | 0.40 | 0.06 | -0.15 | -0.03 | 0.28 | 0.57 | 5.30 | N/A | N/A | N/A | N/A |